Home > Companies > Healthcare Management Solutions

Healthcare Management Solutions

HMSBilling.com

Healthcare Management Solutions (HMS) is a Practice Management Company. We perform our services in such a way as to allow you to practice medicine the way you want to. That is to provide the best possible patient care. Many billing companies bill your patient charges and collect what they can from the insurance companies. They send statements and collect what they can from the patients. There is much more your billing company can, and should do for you.

C-Suite On Deck

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Events

8th International Conference on Bio-Sensing Technology

Conference

Bio-IT Conference & Expo

Conference

Related News

Industry Outlook

SOMALOGIC PARTNERS WITH CITOGEN TO EXPAND AUTHORIZED SITE PROGRAM IN EUROPE

Globenewswire | June 13, 2023

SomaLogic, Inc., a leader in proteomics technology, announced their collaboration with Citogen, the Longwood Group’s customer services and support unit, to establish the company’s first authorized site in Spain. As part of the agreement, Citogen will offer the 7,000-plex SomaScan® Assay and provide SomaScan data to their customers in Southern Europe supporting biological research across an array of disciplines including clinical research, population health studies and nutri...

Cell and Gene Therapy

LUNAPHORE AND NUCLEAI ANNOUNCE A PARTNERSHIP TO PROVIDE AIPOWERED SPATIAL BIOLOGY ANALYSIS TO ACCELERATE DRUG DEVELOPMENT

Lunaphore and Nucleai | September 09, 2022

Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Nucleai, a leader in AI-powered spatial biology transforming precision medicine by unlocking the power of pathology data announced a collaboration to accelerate the discovery of novel biomarkers and drug targets using the latest spatial imaging and machine learning technologies. “We are thrilled to announce the partnership with Lunaphore and...

NOVAVAX SELECTS AGC BIOLOGICS TO MANUFACTURE MATRIX-M™ ADJUVANT FOR NOVEL COVID-19 VACCINE

AGC Biologics | June 03, 2020

AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced that it will partner with Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, on large-scale GMP production of a critical component of Novavax' coronavirus vaccine candidate, NVX-CoV2373. AGC Biologics will manufacture Matrix-M™, the adjuvant component of the vaccine, in order to enhan...

Industrial Impact

MEMED RAISES $93M TO ACCELERATE COMMERCIALIZATION OF ITS HOST IMMUNE-RESPONSE PRODUCT PORTFOLIO

MeMed | January 10, 2022

MeMed, a leader in host response technologies, announces a $93 million private financing round, bringing total funding in the Company to over $200 million, including support from the U.S. Department of Defense and EU Commission. Funds will be used to scale up manufacturing, accelerate commercialization and expand MeMed’s pioneering host immune response product portfolio. MeMed’s technology suite decodes the body’s immune response within minutes, providing p...

Industry Outlook